Related Experiment Video

Updated: Jun 15, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Uncoupling JAK3 activation induces apoptosis in human lymphoid cancer cells via regulating critical survival pathways

Zsuzsanna S Nagy1, Jeremy A Ross, Georgialina Rodriguez

  • 1Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX 79968, USA. znagy@utep.edu

FEBS Letters
|March 10, 2010
PubMed

Insights

Specific inhibition of Janus tyrosine kinase 3 (JAK3) with NC1153 triggers apoptosis in leukemia/lymphoma cells. JAK3 inhibition reveals novel therapeutic targets for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Janus tyrosine kinase 3 (JAK3) plays a critical role in cytokine signaling pathways.
  • Dysregulation of JAK3 signaling is implicated in various lymphoid malignancies.

Purpose of the Study:

  • To investigate the effects of specific Janus tyrosine kinase 3 (JAK3) inhibition using NC1153 on leukemia/lymphoma cell lines.
  • To identify JAK3-dependent survival pathways and potential therapeutic targets in lymphoid tumors.

Main Methods:

  • Treatment of leukemia/lymphoma cell lines with NC1153, a specific JAK3 inhibitor.
  • Affymetrix microarray profiling to analyze gene expression changes.
  • Analysis of gene regulation in JAK3-positive and JAK3-negative lymphoid tumor cells and primary lymphoma samples.

Main Results:

  • NC1153 treatment induced apoptosis in specific leukemia/lymphoma cell lines.
  • JAK3 inhibition modulated survival pathways including p53, TGF-beta, TNFR, and ER stress.
  • IL-2 responsive genes targeted by NC1153 were regulated in JAK3-positive lymphoid tumors but not in JAK3-negative ones.
  • Reciprocal gene regulation was observed in primary lymphoma samples during disease progression and upon JAK3 inhibition.

Conclusions:

  • Specific JAK3 inhibition via NC1153 is a promising strategy for inducing apoptosis in lymphoid malignancies.
  • JAK3 downstream targets represent potential novel therapeutic targets for cancer treatment.
  • Understanding JAK3-dependent pathways can inform the development of new cancer therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...